THEY'RE LYING TO YOU ABOUT PEPTIDES!

Summary

The main theme is an FDA announcement regarding the potential reclassification of seven peptides, including injury repair agents like BPC-157 and TB-500, tissue repair peptides like KPV, metabolic enhancers like MOTS-c, and cognitive/sleep aids like DSIP, Epithalon, and C-max. This shift signifies a move towards potential legalization and broader access. The practical takeaway is that these compounds, previously restricted, may soon be more readily available for therapeutic and performance-enhancing applications.